Therefore, reducing the level of TFDP3 is an ideal way to restore the E2F physiological function and thereby recover the normal apoptosis rate in cells, which could improve the survival of patients with prostate cancer and other carcinomas. The gene discussed is TFDP3; the disease is prostate cancer.